| Literature DB >> 24168272 |
Feng Cong, Xiaoli Liu, Zongxi Han, Yuhao Shao, Xiangang Kong, Shengwang Liu1.
Abstract
BACKGROUND: Infectious bronchitis virus (IBV), a prototype of the Coronaviridae family, is an economically important causative agent of infectious bronchitis in chickens and causes an acute and highly contagious upper respiratory tract infections that may lead to nephritis. However, the molecular antiviral mechanisms of chickens to IBV infection remain poorly understood. In this study, we conducted global gene expression profiling of chicken kidney tissue after nephropathogenic IBV infection to better understand the interactions between host and virus.Entities:
Mesh:
Year: 2013 PMID: 24168272 PMCID: PMC3870970 DOI: 10.1186/1471-2164-14-743
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Primers and probes used for the RT-PCR assays
| STAT1 | NM_001012914 | AAGCAAACGTAATCTTCAGGATAAC | (FAM)-CAAGAAGACCCGATACACATGGCAA-(BHQ1) | TTTCTCTCCTCTTTCAGACAGTTG |
| ISG12-2 | NM_001001296 | TTCCACTATCCAGTCTATCTCAATG | (FAM)-ACCTGCTCCTGGACCGATGCTTCTT-(BHQ1) | GTGAATCTGTCTGTAAAGGATGAAC |
| SOCS3 | NM_204600 | ACTGCGCCCCAGGTGATG | (FAM)-CTCCCGGCAGCAGCACCCC-(BHQ1) | GGGAACTTGCTGTGGGTGAC |
| TNFAIP6 | NM_001037837 | GAGGCAGCGAGAAAAATAGGTTTC | (FAM)-CCATCCAGCCAGCAGCACACAC-(BHQ1) | GCTTTTACTATGGGGTAACCAACTC |
| IRG1 | NM_001030821 | TCCGAGATGTGGGCAAAGAC | (FAM)-TCGCTTGCTTCTCTGAATGACCACA-(BHQ1) | CCTACTCCAAGGGTATCCAGAATC |
| SPP1 | NM_204535 | CCAGAACAGCCGGACTTTC | (FAM)-TGACATTCCTAGCAAGAGCCAAGAG-(BHQ1) | TGGAATCATTGTCATCATCATCATC |
| 18S | FM165414 | GGTTGCAAAGCTGAAACTTAAAGG | (FAM)-ACTCCTGGTGGTGCCCTTCCGTCAA-(BHQ1) | TGAGGTTTCCCGTGTTGAGTC |
| IFIT5 | XM_421662 | AAAAGAAGGCAAATCATGAGTACC | (FAM)-AATTCCTTGAAGAACTCCCTGCTGC-(BHQ1) | TGATCCTCTATTGATTCTTCCAGAC |
| MX1 | NM_204609 | AGAAAGCAATAAGAAAAGCCCAAG | (FAM)-AATGCTACCATTAGTGCCAGCCAC-(BHQ1) | ACCAGATTTCAAGGGAAATTAGTTC |
| OASL | NM_205041 | AGCACTGGTACAAGGAGATGTTG | (FAM)-CTGAAGTCCTCCCTGCCTGTGCCCT-(BHQ1) | CCAAGCAGCTCCAGCACAG |
| RSAD2 | XM_426208 | CTTAAGGAGGCGGGAATGGAG | (FAM)-TTGCTCACAATGCTGACGCTTGGC-(BHQ1) | TTGAACCACCGTTCCCTGATC |
Figure 1Renal lesions associated with IB caused by IBV strain ck/CH/LDL/091022. Note swollen kidneys with tubules and ureters distended with urates.
Figure 2GO category based on biological processes for differentially expressed genes. The significant GO category for differentially expressed genes, the DE genes mainly clustered into 12 functional groups with varied numbers. p-value < 0.05 and FDR < 0.05 were used as a threshold to select significant GO categories. Exact p-value calculation for GO category in Additional file 1.
DE genes associated with immune and inflammatory responses
| MALT1 | XM_413722 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | +2.847583 | |
| CLU | NM_204900 | clusterin | +9.196763 | |
| DMBT1 | CR353989 | deleted in malignant brain tumors 1 | +2.036204 | |
| DUSP4 | NM_204838 | dual specificity phosphatase 4 | +19.50851 | |
| DUSP6 | NM_204354 | dual specificity phosphatase 6 | +2.1367393 | |
| DUSP10 | NM_001031044 | dual specificity phosphatase 10 | +2.5124102 | |
| LY96 | BX931181 | lymphocyte antigen 96 | +4.2568717 | |
| SAMHD1 | NM_001030845 | SAM domain and HD domain 1 | +5.7296877 | |
| ERAP1 | AJ851612 | endoplasmic reticulum aminopeptidase 1 | +5.731377 | |
| HMGB1 | NM_204902 | high mobility group box 1 | +3.24355 | |
| TMEM173 | CR354327 | transmembrane protein 173 | +9.81937 | |
| CFI | XM_426329 | complement factor I | +5.3699164 | |
| IL1R1 | NM_205485 | interleukin 1 receptor, type I | +2.814695 | |
| IRAK2 | NM_001030605 | interleukin-1 receptor-associated kinase 2 | +2.1085246 | |
| IRF7 | NM_205372 | interferon regulatory factor 7 | +4.334887 | |
| JUN | NM_001031289 | jun proto-oncogene | +3.481312 | |
| MAP3K14 | NM_001030927 | mitogen-activated protein kinase kinasekinase 14 | +2.0599 | |
| MYD88 | NM_001030962 | myeloid differentiation primary response gene (88) | +2.0273855 | |
| NCF2 | CR391316 | neutrophil cytosolic factor 2 | +9.767744 | |
| NFKB2 | NM_204413 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | +4.372285 | |
| MASP1 | NM_213586 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | -5.984035 | |
| PELI1 | NM_001012872 | pellino homolog 1 (Drosophila) | -2.6004448 | |
| SIGIRR | NM_001199542 | single immunoglobulin and toll-interleukin 1 receptor (TIR) domain | -3.878401 | |
| MRPS6 | NM_001031486 | mitochondrial ribosomal protein S6 | -7.8250012 | |
| IFIH1 | NM_001193638 | interferon induced with helicase C domain 1 | +11.25022 | |
| SRPK1 | XM_419265 | SFRS protein kinase 1 | +2.4798062 | |
| TLR4 | NM_001030693 | toll-like receptor 4 | +2.019901 | |
| TLR5 | CR353090 | toll-like receptor 5 | -2.4051092 | |
| C1R | XM_416518 | complement component 1, r subcomponent | +13.635473 | |
| C1S | NM_001030777 | complement component 1, s subcomponent | +16.500757 | |
| C3 | NM_205405 | complement component 3 | +25.31715 | |
| C4BPA | NM_204664 | complement component 4 binding protein, alpha | -2.476029 | |
| C8B | BX934795 | complement component 8, beta polypeptide | -2.8326783 | |
| TRIM25 | XM_415653 | tripartite motif-containing 25 | +3.5009384 | |
| COLEC12 | NM_001039599 | collectin sub-family member 12 | -11.011364 | |
| ITCH | XM_417330 | itchy homolog E3 ubiquitin protein ligase (mouse) | +2.3843937 | |
| MARCO | NM_204736 | macrophage receptor with collagenous structure | -3.0318317 | |
| FADD | XM_421073 | Fas (TNFRSF6)-associated via death domain | -2.127713 | |
| IL18R1 | NM_001145225 | interleukin 18 receptor 1 | +3.5603435 | |
| VNN1 | NM_001039288 | vanin 1 | +30.900112 | |
| IL1RL1 | NM_204275 | interleukin 1 receptor-like 1 | -9.989544 | |
| ADAR | AM179858 | adenosine deaminase, RNA-specific | +2.2560015 | |
| USP18 | CR354286 | ubiquitin specific peptidase 18 | +14.18105 | |
| EGR1 | CR389000 | early growth response 1 | +4.516151 | |
| IRF8 | NM_205416 | interferon regulatory factor 8 | +4.638908 | |
| IFI35 | BX934680 | interferon-induced protein 35 | +4.3734093 | |
| IFNGR1 | NM_001130387 | interferon gamma receptor 1 | +2.4954834 | |
| IL6 | NM_204628 | interleukin 6 (interferon, beta 2) | +75.02113 | |
| IL13RA2 | NM_001048078 | interleukin 13 receptor, alpha 2 | +5.0171814 | |
| IRF1 | NM_205415 | interferon regulatory factor 1 | +7.012157 | |
| IRF7 | NM_205372 | interferon regulatory factor 7 | +4.334887 | |
| LIFR | NM_204575 | leukemia inhibitory factor receptor alpha | +2.3569908 | |
| MX1 | NM_204609 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | +48.569965 | |
| NCAM1 | NM_001242604 | neural cell adhesion molecule 1 | -7.5168643 | |
| IP6K2 | NM_001030596 | inositol hexakisphosphate kinase 2 | +2.4397569 | |
| PML | XM_413690 | promyelocytic leukemia | +3.3186321 | |
| ZC3H15 | NM_001006510 | zinc finger CCCH-type containing 15 | -2.916313 | |
| B2M | NM_001001750 | beta-2-microglobulin | +6.515671 | |
| PTPN1 | L20630 | protein tyrosine phosphatase, non-receptor type 1 | +3.4228158 | |
| PTPN2 | NM_001199387 | protein tyrosine phosphatase, non-receptor type 2 | +2.9723573 | |
| CX3CL1 | NM_001077232 | chemokine (C-X3-C motif) ligand 1 | +10.652483 | |
| STAT1 | NM_001012914 | signal transducer and activator of transcription 1, 91 kDa | +12.110944 | |
| STAT3 | NM_001030931 | signal transducer and activator of transcription 3 (acute-phase response factor) | +3.900449 | |
| VCAM1 | BX950651 | vascular cell adhesion molecule 1 | -2.8632648 | |
| OASL | NM_205041 | 2′-5′-oligoadenylate synthetase-like | +101.55924 | |
| SOCS1 | NM_001137648 | suppressor of cytokine signaling 1 | +15.976115 | |
| SOCS3 | NM_204600 | suppressor of cytokine signaling 3 | +30.325502 | |
| CD44 | NM_204860 | CD44 molecule (Indian blood group) | +5.446098 | |
| CD74 | NM_001001613 | CD74 molecule, major histocompatibility complex, class II invariant chain | -7.0005507 | |
| CDO1 | CR353781 | cysteine dioxygenase, type I | -6.4660363 | |
| CEBPB | NM_205253 | CCAAT/enhancer binding protein (C/EBP), beta | +3.5429432 | |
| IL23R | XM_422533 | interleukin 23 receptor | +3.9536817 | |
| EPHX2 | NM_001033645 | epoxide hydrolase 2, cytoplasmic | -2.0498822 | |
| LY96 | BX931181 | lymphocyte antigen 96 | +4.2568717 | |
| BLNK | NM_204908 | B-cell linker | +3.781344 | |
| AOAH | XM_418835 | acyloxyacyl hydrolase (neutrophil) | +3.389245 | |
| AOX1 | NM_001038692 | aldehyde oxidase 1 | -3.0358417 | |
| IGFBP4 | NM_204353 | insulin-like growth factor binding protein 4 | -2.5591307 | |
| IL6 | NM_204628 | interleukin 6 (interferon, beta 2) | +75.02113 | |
| IRAK2 | NM_001030605 | interleukin-1 receptor-associated kinase 2 | +2.1085246 | |
| KNG1 | XM_422766 | kininogen 1 | -2.1926415 | |
| LIPA | AJ719682 | lipase A, lysosomal acid, cholesterol esterase (Wolman disease) | +3.7113423 | |
| LY75 | NM_001037836 | lymphocyte antigen 75 | +3.9913418 | |
| NGFB | M26810 | nerve growth factor, beta polypeptide | -2.035398 | |
| NOX4 | NM_001101829 | NADPH oxidase 4 | -9.4226265 | |
| F11R | NM_001083366 | F11 receptor | +4.464096 | |
| GAL | NM_001159678 | galaninprepropeptide | +8.09671 | |
| SERPINA1 | BX932103 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | -30.80776 | |
| S100A9 | X61200 | S100 calcium binding protein A9 | +32.001503 | |
| CCL4 | NM_001030360 | chemokine (C-C motif) ligand 4 | +10.783558 | |
| CCL17 | XM_414018 | chemokine (C-C motif) ligand 17 | +4.898831 | |
| CCL19 | BX929857 | chemokine (C-C motif) ligand 19 | +2.0884924 | |
| CCL20 | NM_204438 | chemokine (C-C motif) ligand 20 | +4.089286 | |
| BMP2 | NM_204358 | bone morphogenetic protein 2 | +3.6641774 | |
| TLR5 | CR353090 | toll-like receptor 5 | -2.4051092 | |
| TNFAIP6 | NM_001037837 | tumor necrosis factor, alpha-induced protein 6 | +51.35508 | |
| C3 | NM_205405 | complement component 3 | +25.31715 | |
| SCG2 | BX932277 | secretogranin II (chromogranin C) | +3.5667899 | |
| ITCH | XM_417330 | itchy homolog E3 ubiquitin protein ligase (mouse) | +2.3843937 | |
| VNN1 | NM_001039288 | vanin 1 | +30.900112 | |
| NMI | BX950337 | N-myc (and STAT) interactor | +3.1200686 | |
| CHST2 | XR_027120 | carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 | -2.5672126 | |
| HDAC9 | CR354257 | histone deacetylase 9 | -6.544272 |
Genes were considered significantly up-regulated or down-regulated if the change in their relative expression levels was ≥ 2-fold or ≤ -2-fold.
The DE genes associated with innate immune response, cytokine-mediated signaling pathway, and inflammatory responses were assigned based on GO term. Most genes could also be classified into other categories, but only innate immune response, cytokine-mediated signaling pathway, and inflammatory responses were considered.
+: up-regulated;-: down-regulated.
Validation of microarray data by qRT-PCR
| ISG12-2 | NM_001001296 | +141.21 | +197.36 |
| SPP1 | NM_204535 | +19.54 | +3.66 |
| IRG1 | NM_001030821 | +21.26 | +4.28 |
| STAT1 | NM_001012914 | +16.57 | +14.60 |
| TNFAIP6 | NM_001037837 | +136.96 | +3.33 |
| IFITM3 | XM_420925 | +422.64 | +234.00 |
| SOCS3 | NM_204600 | +24.75 | +9.86 |
| IL6 | NM_204628 | +97.97 | +490.15 |
| IFIT5 | XM_421662 | +130.57 | +84.17 |
| RSAD2 | XM_426208 | +165.91 | +193.13 |
| MX1 | NM_204609 | +91.194 | +16.60 |
| OASL | NM_205041 | +185.05 | +22.07 |
qRT-PCR results of 12 immune and inflammatory response related genes in kidney tissues from IBV-infected chickens compared to those of control chickens. qRT-PCR levels of RNA for a given gene were normalized against the 18S RNA. “+” indicates up-regulated genes.
Figure 3KEGG pathway analysis for differentially expressed genes. The significant pathway for differentially expressed genes. A p-value < 0.05 and FDR < 0.05 were used as a threshold to select significant KEGG pathways. Exact p-value calculation for KEGG pathway analysis in Additional file 2.
Figure 4STRING analysis of the relationship between DE genes related to innate immune response, cytokine-mediated signaling pathways, and inflammatory response related genes. The network nodes represent the proteins encoded by the DE genes. Seven different colored lines link a number of nodes and represent seven types of evidence used in predicting associations. A red line indicates the presence of fusion evidence; a green line represents neighborhood evidence; a blue line represents co-ocurrence evidence; a purple line represents experimental evidence; a yellow line represents text-mining evidence; a light blue line represents database evidence, and a black line represents co-expression evidence.